Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 11/20 | 0.40 |
| ▸ | EGFR | P00533 | 8/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | FECH | P22830 | 1/20 | 0.40 |
| ▸ | MYH14 | Q7Z406 | 1/20 | 0.40 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.40 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.38 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13655122 | 0.86 | ERBB2 (0.47) | ERBB2EGFRNQO2FECHMYH14 | |
| SCHEMBL3484112 | 0.84 | EGFR (0.38) | ERBB2EGFRNQO2FECHMYH14 | |
| SCHEMBL29887886 | 0.84 | EGFR (0.38) | ERBB2EGFRNQO2FECHMYH14 | |
| SCHEMBL15703717 | 0.84 | CYP2C19 (0.40) | ERBB2EGFRNQO2FECHMYH14 | |
| SCHEMBL12524904 | 0.82 | SCN5A (0.39) | ERBB2EGFRERBB3ERBB4MEN1 | |
| SCHEMBL26580265 | 0.81 | ERBB2 (0.42) | ERBB2EGFRNQO2FECHMYH14 | |
| SCHEMBL18181595 | 0.80 | TEAD4 (0.38) | ERBB2EGFRNQO2FECHMYH14 | |
| SCHEMBL24569945 | 0.79 | PDE7A (0.52) | MEN1KMT2A | |
| SCHEMBL29834731 | 0.79 | PDE7A (0.52) | MEN1KMT2A | |
| SCHEMBL26894024 | 0.78 | ERBB2 (0.43) | ERBB2EGFRNQO2FECHMYH14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2680850-B1 | ALKYNE SUBSTITUTED QUINAZOLINE COMPOUND AND METHODS OF USE | NEWGEN THERAPEUTICS INC (US) | 2018-05-23 | — | — | EP | disclosed |